A diversity supplement is funding for which a scientific researcher can apply to allow for the addition of a trainee from an underrepresented minority group to an existing NIH-funded project team to further that trainee’s education and career development.
Dr. Kevin Oeffinger, director of the Duke Cancer Institute Supportive Care and Survivorship Center, currently seeks a trainee for inclusion in a diversity supplement to a project to improve the management and outcomes of cancer patients, both during and after treatment, using a multi-level intervention. The project, ONE TEAM, is an 18-month clustered randomized controlled trial that seeks to integrate primary care at the time of a patient’s cancer diagnosis, employing both patient and primary care physician strategies to optimize the management of cardiovascular disease comorbidities.
For this diversity supplement opportunity, Dr. Oeffinger would like to recruit a post-doctoral student or junior faculty member for a 1+-year commitment as part of the research team. The ideal candidate will possess an interest in primary care, oncology, care coordination, and/or medication adherence.
Please contact Dr. Oeffinger or Dr. Leah Zullig with questions about the role and/or its requirements. If you’re interested in pursuing this opportunity, please email your expression of interest, as well as a current C.V., to Amanda McMillan by no later than December 31. The selected candidate will participate in assembling the diversity supplement application and so should be available to do so during the early part of 2021.